Glenmark Pharma gets tentative USFDA nod for skin treatment drug

Glenmark Pharmaceuticals Monday said it has received a tentative nod from the US health regulator for Clobetasol Propionate foam, used to treat inflammation and itching caused by a number of skin conditions like eczema.

For more information on stock tips
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co


Connect with our social media sites

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Follow @Epic_Research

Posted in: Indian Market Tips